GlassScriptPhysician profile
Leslie C Jacobs
NPI 1831262393
$332.30
in general payments reported to CMS, 2019-2025
14 companies · $50.43 in 2025
The $50.43 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2022: $25.83 · 2023: $49.17 · 2025: $50.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $99.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $99.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $43.51 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.67 | 2019 | |
| Boston Scientific Corporation | $30.40 | 2025 | Watchman Flx |
| Glaxosmithkline, LLC. | $29.20 | 2019 | |
| Abbott Laboratories | $28.26 | 2023 | Freestyle Libre 2 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.62 | 2019 | |
| Horizon Therapeutics Plc | $24.03 | 2019 | |
| Novo Nordisk INC | $20.91 | 2023 | |
| Amgen INC. | $20.03 | 2025 | Krystexxa |
| Mylan Specialty L.P. | $18.79 | 2019 | |
| Amarin Pharma, INC. | $13.29 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.19 | 2022 | |
| Nalpropion Pharmaceuticals LLC | $12.76 | 2019 | |
| Optos, INC. | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.